Health Innoventures - Home



about us

the team

investment criteria

portfolio

for limited partners only

contact us

publications

vision


mission statement

Bear Stearns Health Innoventures seeks to invest in private companies with innovative R&D.

Specifically the fund will focus in the areas of biotechnology - the platform to reverse the "innovation deficit" in the pharmaceutical industry.

Specific investment criteria:

Bear Stearns Health Innoventures generally prefers to be the lead investor

Typical initial investment amount will range from $7.5 to 10 million



_up

© 2001-08 JPMorgan Chase & Co.